Mallinckrodt plc to Report Earnings Results for Second Quarter 2025
Mallinckrodt (NYSE:MNK), a global specialty pharmaceutical company, has scheduled its second quarter 2025 financial results announcement for Wednesday, August 6, 2025. The company will host an investor conference call at 8:30 a.m. ET.
Investors can participate through multiple channels, including a live dial-in registration system and an audio-only webcast. The presentation will also be accessible through Mallinckrodt's Investor Relations website.
Mallinckrodt (NYSE:MNK), un'azienda farmaceutica specializzata a livello globale, ha programmato l'annuncio dei risultati finanziari del secondo trimestre 2025 per mercoled矛 6 agosto 2025. La societ脿 terr脿 una conference call per gli investitori alle 8:30 ET.
Gli investitori potranno partecipare tramite diversi canali, tra cui un sistema di registrazione per chiamate in diretta e una webcast solo audio. La presentazione sar脿 inoltre disponibile sul sito web delle Relazioni con gli Investitori di Mallinckrodt.
Mallinckrodt (NYSE:MNK), una compa帽铆a farmac茅utica especializada a nivel global, ha programado el anuncio de sus resultados financieros del segundo trimestre de 2025 para el mi茅rcoles 6 de agosto de 2025. La empresa realizar谩 una conferencia telef贸nica para inversores a las 8:30 a.m. ET.
Los inversores podr谩n participar a trav茅s de varios canales, incluyendo un sistema de registro para llamadas en vivo y una transmisi贸n en l铆nea solo de audio. La presentaci贸n tambi茅n estar谩 disponible en el sitio web de Relaciones con Inversores de Mallinckrodt.
Mallinckrodt (NYSE:MNK)電� 旮�搿滊矊 鞝勲 鞝滌暯須岇偓搿滌劀 2025雲� 2攵勱赴 鞛 鞁れ爜 氚滍憸毳� 2025雲� 8鞗� 6鞚� 靾橃殧鞚�搿� 鞓堨爼頄堨姷雼堧嫟. 須岇偓電� 霃欕秬 響滌鞁� 鞓れ爠 8鞁� 30攵�鞐� 韴瀽鞛� 旎嵓霟办姢 旖滌潉 臧滌禍頃� 鞓堨爼鞛呺媹雼�.
韴瀽鞛愲摛鞚� 霛检澊敫� 鞝勴檾 霌彪 鞁滌姢韰滉臣 鞓る敂鞓� 鞝勳毄 鞗轨簮鞀ろ姼 霌� 雼れ枒頃� 毂勲剱鞚� 韱淀暣 彀胳棳頃� 靾� 鞛堨姷雼堧嫟. 氚滍憸 鞛愲電� Mallinckrodt 韴瀽鞛� 甏�瓿� 鞗轨偓鞚错姼鞐愳劀霃� 頇曥澑頃� 靾� 鞛堨姷雼堧嫟.
Mallinckrodt (NYSE:MNK), une entreprise pharmaceutique sp茅cialis茅e 脿 l鈥櫭ヽhelle mondiale, a programm茅 l鈥檃nnonce de ses r茅sultats financiers du deuxi猫me trimestre 2025 pour le mercredi 6 ao没t 2025. La soci茅t茅 organisera une conf茅rence t茅l茅phonique pour les investisseurs 脿 8h30 ET.
Les investisseurs pourront participer via plusieurs canaux, y compris un syst猫me d鈥檌nscription pour appels en direct et un webcast audio uniquement. La pr茅sentation sera 茅galement accessible sur le site des Relations Investisseurs de Mallinckrodt.
Mallinckrodt (NYSE:MNK), ein globales Spezialpharmaunternehmen, hat die Ver枚ffentlichung der Finanzergebnisse f眉r das zweite Quartal 2025 f眉r Mittwoch, den 6. August 2025 angek眉ndigt. Das Unternehmen wird um 8:30 Uhr ET eine Telefonkonferenz f眉r Investoren abhalten.
Investoren k枚nnen 眉ber verschiedene Kan盲le teilnehmen, darunter ein Live-Anmeldesystem f眉r Telefonate und einen reinen Audio-Webcast. Die Pr盲sentation wird auch auf der Investor-Relations-Website von Mallinckrodt verf眉gbar sein.
- None.
- None.
A conference call for investors will begin at聽8:30 a.m.聽ET and can be accessed as follows:
- Live Call Participant Registration (including dial-in):
- Audio-Only Webcast Link (live and replay:
- On the Investor Relations page of the聽Mallinckrodt聽website:聽https://ir.mallinckrodt.com/
ABOUT MALLINCKRODT
Mallinckrodt is a global business consisting of multiple wholly owned subsidiaries that develop, manufacture, market and distribute specialty pharmaceutical products and therapies. The Company's Specialty Brands reportable segment's areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, hepatology, nephrology, pulmonology, and ophthalmology; neonatal respiratory critical care therapies; and gastrointestinal products. Its Specialty Generics reportable segment includes specialty generic drugs and active pharmaceutical ingredients. To learn more about Mallinckrodt, visit聽www.mallinckrodt.com.
Mallinckrodt uses its website as a channel of distribution of important company information, such as press releases, investor presentations and other financial information. It also uses its website to expedite public access to time-critical information regarding the Company in advance of or in lieu of distributing a press release or a filing with the聽U.S. Securities and Exchange Commission聽("SEC") disclosing the same information. Therefore, investors should look to the Investor Relations page of the website for important and time-critical information. Visitors to the website can also register to receive automatic e-mail and other notifications alerting them when new information is made available on the Investor Relations page of the website.
Investor Relations Contact
Bryan Reasons
Executive Vice President and Chief Financial Officer
[email protected]
Mallinckrodt, the "M" brand mark and the聽Mallinckrodt Pharmaceuticals聽logo are trademarks of a Mallinckrodt company.聽漏听2025.
View original content to download multimedia:
SOURCE Mallinckrodt plc
FAQ
When will Mallinckrodt (MNK) report Q2 2025 earnings?
What time is Mallinckrodt's Q2 2025 earnings call?
How can investors access Mallinckrodt's Q2 2025 earnings call?
Where can I find Mallinckrodt's Q2 2025 earnings webcast?
